Biomedical Innovation

Duke-Margolis, in partnership with FDA and a wide array of other stakeholder groups, is focused on improving the process of medical product development and regulatory review to increase the treatment options available to patients and the value that these products can introduce into the health care system. Our works centers on the following areas:

Regulatory Science
Medical Product Pricing and Payment
Real-World Evidence
Artificial Intelligence and Clinical-Decision Making Software

Project

21st Century Cures Act 2.0

Project

Real-World Evidence Collaborative

Project

Artificial Intelligence in Health Care

Project

Opioids and Substance Use

Project

Alzheimer's

Project

Antimicrobial Incentives and Payment Reform

Combating the growing threat of antimicrobial resistance (AMR) requires generation of innovative...

Project

Integrated Pain Management: Lessons from North Carolina Health Systems and Beyond

Vignesh Alagappan

2020 Margolis Intern

Nancy Allen LaPointe

Faculty Fellow, Duke-Margolis Center for Health Policy
Adjunct Associate Professor in the Department of Medicine Faculty

Adam Aten, MPH, MSc

Research Associate

Laura Benzing

2020 Margolis Intern

Milena Berhane, M.P.H.

Policy Analyst

Hayden Bosworth, PhD

Professor in Population Health Sciences
Margolis Affiliated Faculty

Beth Boyer, MPH

Research Associate

Brian Canter, Ph.D.

Senior Policy Analyst

Ethan Chupp

Policy Analyst

Matt D'Ambrosio

Research Assistant

Michelle DelFavero

Research Associate

Nick Fiore

Senior Policy Analyst

Nikhil Gadiraju

2020 Margolis Intern

Victoria "Tori" Gemme, MBA

Research Associate

Hannah Graunke, MMP

Policy Analyst

Marianne Hamilton Lopez, PhD, MPA

Senior Research Director, Biomedical Innovation
Adjunct Associate Professor
Senior Team Member
Margolis Core Faculty

Nicholas R. Harrison, MPH, MA

Research Associate

Regina LaBelle, JD

Principal, LaBelle Strategies
Visiting Fellow

Trevan Locke, PhD

Research Associate

Herbert Kim Lyerly, MD

George Barth Geller Distinguished Professor of Surgery
Margolis Core Faculty

Mark McClellan, MD, PhD

Director of Margolis Center
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty

Valerie Parker

Policy Analyst

Caleigh Propes

Research Assistant

Arti K. Rai, JD

Elvin R. Latty Professor of Law
Margolis Core Faculty

Derick Rapista

Research Assistant

Rebecca (Becky) Ray

Senior Policy Analyst

David Ridley, PhD

Dr. and Mrs. Frank A. Riddick Professor of the Practice of Business Administration
Margolis Executive Core Faculty

Thomas Roades, MPP

Policy Analyst

Morgan Romine, MPA

Chief of Staff
Senior Team Member

Gillian Sanders Schmidler, PhD

Deputy Director, Margolis Center
Professor of Population Health Sciences, School of Medicine
Margolis Executive Core Faculty
Anti-Racism and Equity Committee Member

Sarah Sheehan, MPA

Assistant Research Director
Senior Team Member

Christina Silcox, PhD

Digital Health Policy Fellow
Adjunct Assistant Professor
Senior Team Member
Margolis Core Faculty

Frank Sloan, PhD

J. Alexander McMahon Distinguished Professor Emeritus of Health Policy and Management

Corinna Sorenson, PhD

Director of Graduate Education Initiatives and the Margolis Scholars Program
Assistant Professor in Population Health Sciences
Margolis Core Faculty
Anti-Racism and Equity Committee Member

Erin Soule, Ph.D.

Assistant Research Director

Elizabeth Staton

Policy Analyst

Sreekanth Vemulapalli, MD

Assistant Professor of Medicine
Margolis Core Faculty

Event 5/12/2021

Combating Rising Antimicrobial Resistance: Advancing Public Health Preparedness, Antibiotics, & Innovation

Combating Rising Antimicrobial Resistance: Advancing Public Health Preparedness, Infrastructure, &…

Event 4/19/2021

Building a Resilient Drug Supply Chain

The Duke-Margolis Center for Health Policy is convening a public webinar to discuss how to build a…

Event 2/16-2/17/2021

Evaluating RWE from Observational Studies in Regulatory Decision-Making: Lessons Learned from Trial Replication Analyses

Observational (non-interventional) studies—typically involving analyses of real-world data (RWD)…

Event 2/2-2/3/2021

Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials

Pregnant people have historically been excluded from clinical trials for new and existing…

Policy Brief

Cures 2.0: Modernizing Access for Breakthrough Devices

Beena Bhuiyan Khan, Hannah Graunke, Rebecca Ray, Morgan Romine, Marianne Hamilton Lopez, Mark McClellan

2021

Policy Brief

Cures 2.0: Building a Modern Health Data Infrastructure

Trevan Locke, Rebecca Ray, Rachele Hendricks‐Sturrup, Marianne Hamilton Lopez, Morgan Romine, Mark McClellan

2021

Journal Article

Advancing Therapeutic Development for Pulmonary Morbidities Associated with Preterm Birth

Sarah Sheehan, Gerri Baer, Morgan Romine, Lynn Hudson, Robert Lim, Elektra Papadopoulos, Michelle Campbell, Gregory Daniel, Susan McCune

2020

Journal Article

FDA postmarketing safety labeling changes: What have we learned since 2010 about impacts on prescribing rates, drug utilization, and treatment outcomes

Matthew Rosenberg, Sarah Sheehan, Esther Zhou, Ellen Pinnow, Jessica Burnell, Morgan Romine, Gerald Dal Pan

2020

News Update January 10, 2021

Biomedical Innovation

Biomedical Innovation

Projects Relating to Biomedical Innovation

Duke-Margolis Faculty & Research Team

Events About Biomedical Innovation

Publications About Biomedical Innovation

News About Biomedical Innovation

Topics Related to Biomedical Innovation